In both phase 3 trials, onabotulinumtoxinA significantly improved platysma band severity at maximum contraction compared with placebo. The Food and Drug Administration (FDA) has approved Botox ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results